User blogs

Two weeks ago, TPG’s Rise Fund invested $200 million in Airtel Mobile Commerce BV (AMC BV) — the mobile money business of London-listed telecom Airtel Africa. After closing the deal, the Bharti Airtel subsidiary noted that it was still in discussions to give up more minority stake (25% of the issued share capital) to more potential investors. 

Today, it has announced another investor — global payments provider Mastercard in a deal that will see Airtel Africa receive an additional $100 million for its mobile money business.

From the statement released, Airtel Africa and Mastercard have “extended commercial agreements and signed a new commercial framework which will deepen their partnerships across numerous geographies and areas including card issuance, payment gateway, payment processing, merchant acceptance and remittance solutions, amongst others.”

AMC BV’s $2.65 billion valuation on a cash and debt-free basis remains unchanged from the last time. And like the deal with The Rise Fund, Mastercard will hold a minority stake in AMC BV upon the completion of the transaction which will close in two tranches — $75 million invested at first close (which will be finalized in the next four months), and $50 million to be invested at the second close.

By selling off a minority stake in the mobile money business to The Rise Fund, Mastercard and other investors, the telecom believes it can raise enough cash to monetize its mobile money business and pursue a possible listing in four years. 

In addition to receiving investments from TPG’s Rise Fund and Mastercard, Airtel Africa has begun selling off some assets as well. Last week, the company sold 1,424 telecommunications towers companies in Madagascar and Malawi to Helios Towers for $119 million. Both Helios and Airtel Africa also agreed to trade tower assets in Chad and Gabon, although the details remain undisclosed.

These efforts are geared towards the company’s pursuit of strategic asset monetisation, investment opportunities, and, ultimately, debt reduction.

“With today’s announcement, we are pleased to welcome Mastercard as an investor in our mobile money business, joining The Rise Fund, which we announced two weeks ago,” CEO of Airtel Africa, Raghunath Mandava said of the investment. “This is a continuation of our strategy to increase the minority shareholding in our mobile money business with the further intention to list this business within four years. We are significantly strengthening our existing strategic relationship with Mastercard to help us realise the full potential from the substantial opportunity to improve financial inclusion across our countries of operation.” 

Many companies had to adapt during the COVID-19 pandemic. For SOSV-backed Achiko, this meant shifting its focus from mobile payment services to affordable COVID-19 screening. Achiko’s platform combines an app called Teman Sehat (“Health Buddy” in Indonesian) for payments and keeping test records, and proprietary low-cost testing kits using DNA aptamers, or synthetic strands of DNA, that are cheaper to manufacture than rapid or PCR tests.

The testing kits, formerly code-named Gumnuts and now called Aptamex, were developed in a partnership with Barcelona-based biotech company RegenaCellx.sl and completed the first phase of its clinical validation trials in January, with the goal of moving to production in the second quarter of this year. Teman Sehat, meanwhile, was built on technology that Achiko had developed for a payments aggregator called Mimopay.

Founded in 2018, Achiko listed on the Swiss Stock Exchange the next year. Chief executive officer Steven Goh told TechCrunch that the company was in the process of expanding into buy now, pay later services in 2020 when COVID-19 disrupted international travel. As a result, the compliance process would have been much more lengthy and expensive. Achiko decided to see what could be created with its existing technology to address the pandemic instead, and launched Teman Sehat as a result.

The app offers incentives for people to get tested, take payments and keep records of test results that could be used for check-ins by workplaces and businesses. While working on Teman Sehat, however, Goh said Achiko’s team realized that the cost of COVID-19 PCR and rapid tests were too high for many people in emerging markets. While frequent mass testing might eventually be accessible in the United States and Europe, Goh told TechCrunch “the actual wholesale costs of rapid tests would be $5 to $8. By the time, you’re actually delivering a rapid test in the field, it could be anything between $20 and $70, and if you’re in a country like the Philippines or Indonesia, that sort of price point is too high.”

Achiko decided Teman Sehat’s potential would be limited unless it was coupled with a low-cost testing solution, and began working with Regenacellx.sl. In January, it appointed Dr. Morris Berrie, co-founder and chairman of TTS Global Initiative, as president to help with the development and production of Aptamex.

Achiko’s team emphasizes it is not meant to be a replacement for PCR and rapid tests. Instead, Aptamex will serve as an affordable screener, costing under 25 cents USD per kit, that can be used frequently (daily or every other day), and people who test positive will be referred to PRC or rapid tests.

Berrie told TechCrunch that the benefit of aptamers is that they are inexpensive to produce and can be ordered from suppliers of synthetic DNA. “It is incredibly cheap and synthetic and the test itself is non-invasive. All these things are big pluses. The most important of all is the price point is a fraction of other testing kits available,” he said.

To use Aptamex, people gargle a mouthwash, spit a sample into a tube and drop it off at a testing center. Then the saliva sample is diluted in Aptamex’s aptamer test conjugate and scanned with a spectrophotometer to see if the aptamers bind to the COVID-19 spike protein. Results are available within an hour and can be sent through Teman Sehat. Phase 1 testing for Aptamex in Indonesia showed results of 91% sensitivity (or how often it correctly showed a positive result) and 85% specificity (or how well it identified true negatives) in field tests.

Procurement and manufacturing for Aptamex tests is currently underway in Taiwan, and Achiko is preparing filings with Indonesia’s Ministry of Health with the target of shipping kits by the beginning of the third quarter. It is also applying for CE certification in Europe and plans to apply for FDA approval in the United States, too.

Goh said aptamers can used to develop tests for other pathogens, and applied in other formats, including microfluidics and electronic sensors. This means Aptamex can be adapted for COVID-19 mutations and eventually be used to screen for other diseases. One potential barrier to the use of aptamers in diagnostics is the lack of standardized protocols and kits, but Achiko believes those can be developed as the cost of chemical synthesis decreases and databases of aptamers are created.

In the future, Achiko will continue to focus on health tech instead of financial products. “There’s no intention to be a financial services platform going forward,” Goh said. “The vision of being able to use a new technology stack to detect first with COVID, but any universe of other pathogens or indications of possible ailments, and having a platform to integrate these things in a contemporary way is something we believe is worthwhile.”

Cendana Capital, a San Francisco-based fund of funds manager, has amassed stakes in more than 100 venture firms since launching in 2010. For the most part, it did this by focusing on managers who are raising funds of $100 million or less in capital, even foregoing stakes in beloved outfits like Forerunner Ventures and Uncork Capital as their assets under management ballooned well beyond that amount.

Yet as the market changed, however, Cendana founder Michael Kim began to play with that formula. Last spring, for example, when he closed on $278 million in new capital commitments, he said planned to invest in the seed-stage managers he has always backed, but that he planned to funnel a small amount of capital to pre-seed managers raising $50 million or less, as well as to invest in a sprinkling of international managers.

Now Kim is back with a brand-new fund that sees him covering even more ground. Called Cendana’s Nano fund, it has raised $30 million in capital from existing Cendana backers to invest in up to 12 investment managers who are piecing together funds of $15 million or less capital. There are simply too many smart people right now making smaller bets for Cendana not to make the move, he suggests. We talked with Kim about the fund — and the changing landscape more broadly — in a chat has been edited lightly for length.

TC: What’s the thesis behind this Nano fund?

MK: The seed market has evolved a lot over the last 18 months to 24 months. You have this whole world of Twitter VC, meaning people who have a lot of strong opinions and an operator-investor perspective, but who may not have substantial funds behind them. You have solo capitalists like Lachy Groom and Josh Buckley, who’ve gone out and raised hundreds of millions of dollars. You also have the AngelList rolling funds. I think there are probably more than 100 rolling funds out there, and probably 95% of them are [headed by] people who are working at the big tech or private tech companies, and it’s more of a vehicle of convenience for their friends to invest alongside them.

TC: And you think they need more capital than is floating out there already?

MK: I think we are the only institutional LP that is focused at this stage, because as you know, many of the funds of funds and university endowments and family offices have to write big checks, so they’re not going to be investing a little bit into a tiny $10 million fund.

TC: What are you looking for exactly?

MK: The goal is to find the next Lowercase Capital. Not everyone knows this, but Chris Sacca’s first fund was $8 million and it returned 250x. Manu Kumar of K9 Ventures — his first fund was $6.25 million and returned 53x. So you can generate substantial alpha with these smaller funds.

Historically, we would meet with fund managers, and when they said, ‘We’re going to raise a $10 million to $15 million fund,’ we were like,’Okay, sounds interesting. Let’s talk when you’re raising your second fund.’ But we realized that we’re missing out an entire segment of the market. So Nano was created to capture that.

TC: Why draw a line in the sand at $15 million?

MK: First, if you’re going to be running a $100 million seed fund, you have to be writing $1.5 million to $2 million checks, and that’s a super competitive space right now, because not only are there other seed funds but also a lot of firms — Founders Fund, Sequoia Capital, Lightspeed, General Catalyst — that are very active at the seed stage. We’re coming across a lot of these managers who want to stay small, because by writing $300,000 to $400,000, they’re not competing against Sequoia or Forerunner Ventures; they’re just sliding into the round.

TC: Do you worry they will just get washed out of that investment later through subsequent checks from bigger players?

MK: Right now, we now have more than 100 portfolio funds within Cendana, and we did some data analysis. We looked at the fund size, and then the average ownership of each fund. And it turns out there’s a baseline of about 15% of a fund, meaning if you’re a $100 million fund, the average ownership stake [you have in your startups] is around 15%. If you’re a $50 million fund, the average ownership is about 7.5%.

We then looked at performance across our fund managers, and it turns out that of funds with $50 million in capital — our better-performing funds — have more ownership than 7.5%. They have more like 10% to 12%. Now, when you look at these tiny funds, if you’re a $15 million fund, 15% of that [should equate to] 2.2% ownership, but we are seeing that these tiny funds are actually getting more like 4% to 5% ownership. They’re punching above their weight because of who is involved.

TC: Who have you backed so far?

MK: The first one is Form Capital, a fund from Bobby Goodlatte and Josh Williams. Both were early at Facebook; Bobby led the team that designed Facebook Photos and was later an [entrepreneur-in-residence] at Greylock. Josh cofounded Gowalla (acquired by Facebook).

TC: How big a fund are they raising and how much are you giving them?

MK: They raised a $15 million fund, and our strategy is to [account for] 20% of [each of these funds], so we wrote them a $3 million check.

The second fund manager is Jeff Morris Jr.; he runs a fund called Chapter One. He was a senior product guy at Tinder and and an active angel, and he raised a $10 million fund last year into which we wrote a $2 million check.

TC: And the third?

MK: The third manager hasn’t closed the fund, so I can’t disclose his name, but he was a very early employee at Uber and ran their data teams.

The last is an interesting example because this person could probably go out and raise $100 million, but to my point about not wanting to compete against everyone in the world in writing a big check, he’s content to write [sub $500,000] checks into interesting data analytics and AI and machine learning companies, and everybody wants him involved because of his experience and his network of data scientists worldwide.

TC: When Chris Sacca dove in, it was his full-time job, I think. Do you care if these managers are focused solely on investing?

MK: No. With Nano we’re investing in people who may actually have a day job, which would not be a fit for our main fund, but with our Nano fund, our aperture is wider. We welcome anyone out there looking to manage $15 million or less to reach out.

TC: Well, to be clear, you have some criteria. What is it?

MK: No matter who we invest in, they have to have investment experience and an investment track record. What we really look for at the end of the day is a person who has some sort of advantage — whether it’s domain expertise or networks. So you could be an amazing computer scientist in Pittsburgh at Carnegie Mellon and if you’ve made some investments [we’d talk with you]. It could be someone coming out of Stripe or PayPal or Facebook or an entrepreneur in Atlanta.

TC: A $30 million fund of funds is going to get committed pretty fast in this market. Is the plan to raise maybe one every year?

MK: We have an incredible top of the funnel, and as you’re alluding, we’re going to be inundated. But we walk in there and try to meet with everybody.

We’re also in discussions with our existing fund managers to create a nano fund for [some of] them. So, you know, imagine one of our fund managers, running a $100 million fund. Why not create a $10 million nano vehicle with them where they could write $250,000 to $500,00 check? They don’t want to fill up their fund with these small checks, but you could see how, if they were to create this smaller vehicle, it could be very interesting for them for a returns perspective.

TC: So you’d write them a check for a third of this nano fund . . .

MK: And their LPs would fill in the rest. I’m sure they’d be excited to do it.

Before you can improve a workflow, you have to understand how work advances through a business, which is more complex than you might imagine inside a large enterprise. That’s where Celonis comes in. It uses software to identify how work moves through an organization and suggests more efficient ways of getting the same work done, also known as process mining

Today, the company announced a significant partnership with IBM where IBM Global Services will train 10,000 consultants worldwide on Celonis. The deal gives Celonis, a company with around 1200 employees access to the massive selling and consulting unit, while IBM gets a deep understanding of a piece of technology that is at the front end of the workflow automation trend.

Miguel Milano, chief revenue officer at Celonis says that digitizing processes has been a trend for several years. It has sped up due to COVID, and it’s partly why the two companies have decided to work together. “Intelligent workflows, or more broadly spoken workflows built to help companies execute better, are at the heart of this partnership and it’s at the heart of this trend now in the market,” Milano said.

The other part of this is that IBM now owns Red Hat, which it acquired in 2018 for $34 billion. The two companies believe that by combining the Celonis technology, which is cloud based, with Red Hat, which can span the hybrid world of on premises and cloud, the two together can provide a much more powerful solution to follow work wherever it happens.

“I do think that moving the [Celonis] software into the Red Hat OpenShift environment is hugely powerful because it does allow in what’s already a very powerful open solution to now operate across this hybrid cloud world, leveraging the power of OpenShift which can straddle the worlds of mainframe, private cloud and public cloud. And data straddle those worlds, and will continue to straddle those worlds,” Mark Foster, senior vice president at IBM Services explained.

You might think that IBM, which acquired robotic process automation vendor, WDG Automation last summer, would simply attempt to buy Celonis, but Foster says the partnership is consistent with the company’s attempt to partner with a broader ecosystem.

“I think that this is very much part of an overarching focus of IBM with key ecosystem partners. Some of them are going to be bigger, some of them are going to be smaller, and […] I think this is one where we see the opportunity to connect with an organization that’s taking a leading position in its category, and the opportunity for that to take advantage of the IBM Red Hat technologies…” he said.

The companies had already been working together for some time prior to this formal announcement, and this partnership is the culmination of that. As this firmer commitment to one another goes into effect, the two companies will be working more closely to train thousands of IBM consultants on the technology, while moving the Celonis solution into Red Hat OpenShift in the coming months.

It’s clearly a big deal with the feel of an acquisition, but Milano says that this is about executing his company’s strategy to work with more systems integrators (SIs), and while IBM is a significant partner it’s not the only one.

“We are becoming an SI consulting-driven organization. So we put consulting companies like IBM at the forefront of our strategy, and this [deal] is a big cornerstone of our strategy,” he said.

From the earliest days of the pandemic, it was no secret that video chat was about to become a very hot space.

Over the past several months investors have bankrolled a handful of video startups with specific niches, ranging from always-on office surveillance to platforms that encouraged plenty of mini calls to avoid the need for more lengthy team-wide meetings. As the pandemic wanes and plenty of startups begin to look towards hybrid office models, there are others who have decided to lean into embracing a fully remote workforce, a strategy that may require new tools.

PingPong, a recent launch from Y Combinator’s latest batch, is building an asynchronous video chat app for the workplace. We selected PingPong as one of our favorite startups that debuted last week.

The company’s central sell is that for remote teams, there needs to be a better alternative to Slack or email for catching up with co-workers across time zones. While Zoom calls might be able to convey a company’s culture better than a post in a company-wide Slack channel, for fully remote teams operating on different continents, scheduling a company-wide meeting is often a non-starter.

PingPong is selling its service as an addendum to Slack that helps remote product teams collaborate and convey what they’re working on. Users can capture a short video of themselves and share their screen in lieu of a standup presentation and then they can get caught up on each other’s progress on their own time. PingPong’s hope is that users find more value in brainstorming, conducting design reviews, reporting bugs and more inside while using asynchronous video than they would with text.

“We have a lot to do before we can replace Slack, so right now we kind of emphasize playing nice with Slack,” PingPong CEO Jeff Whitlock tells TechCrunch. “Our longer term vision is that what young people are doing in their consumer lives, they bring into the enterprise when they graduate into the workforce. You and I were using Instant Messenger all the time in the early 2000s and then we got to the workplace, that was the opportunity for Slack… We believe in the next five or so years, something that’s a richer, more asynchronous video-based Slack alternative will have a lot more interest.”

Building a chat app specifically designed for remote product teams operating in multiple time zones is a tight niche for now, but Whitlock believes that this will become a more common problem as companies embrace the benefits of remote teams post-pandemic. PingPong costs $100 per user per year.